The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Open accessAbstract
To understand why cancer vaccine–induced T cells often do not eradicate tumors, we studied immune responses in mice vaccinated with gp100 melanoma peptide in incomplete Freund's adjuvant (peptide/IFA), which is commonly used in clinical cancer vaccine trials. Peptide/IFA vaccination primed tumor-specific CD8+ T cells, which accumulated not in tumors but rather at the persisting, antigen-rich vaccination site. Once there, primed T cells became dysfunctional and underwent antigen-driven, interferon-γ (IFN-γ)- and Fas ligand (FasL)-mediated apoptosis, resulting in hyporesponsiveness to subsequent vaccination. Provision of CD40-specific antibody, Toll-like receptor 7 (TLR7) agonist and interleukin-2 (IL-2) reduced T cell apoptosis but did not prevent vaccination-site sequestration. A nonpersisting vaccine formulation shifted T cell localization toward tumors, inducing superior antitumor activity while reducing systemic T cell dysfunction and promoting memory formation. These data show that persisting vaccine depots can induce specific T cell sequestration, dysfunction and deletion at vaccination sites; short-lived formulations may overcome these limitations and result in greater therapeutic efficacy of peptide-based cancer vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 1×
“We examined whether persistent gp100 antigen affected pmel-1 T cell function as observed in settings of chronic viral infection and cancer 44, 45 .”
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Matsushita, H., Vesely, M. D., Koboldt, D. C., Rickert, C. G., Uppaluri, R., Magrini, V. J., Arthur, C. D., White, J. M., Chen, Y.-S., Shea, L. K., et al. (2012) · Nature · doi:10.1038/nature10755 · Cited by 1,288
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810097 · Cited by 1,102
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Self-citationgp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J., Gailani, F., Riley, L., Conlon, K., Pockaj, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012863 · Cited by 911
Self-citationSmyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Jin, H.-T., Anderson, A. C., Tan, W. G., West, E. E., Ha, S.-J., Araki, K., Freeman, G. J., Kuchroo, V. K., & Ahmed, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009731107 · Cited by 858
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Baitsch, L., Baumgaertner, P., Devêvre, E., Raghav, S. K., Legat, A., Barba, L., Wieckowski, S., Bouzourene, H., Deplancke, B., Romero, P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46102 · Cited by 845
Complete but curtailed T-cell response to very low-affinity antigen
Zehn, D., Lee, S. Y., & Bevan, M. J. (2009) · Nature · doi:10.1038/nature07657 · Cited by 696
Activated T Cell Death In Vivo Mediated by Proapoptotic Bcl-2 Family Member Bim
Hildeman, D. A., Zhu, Y., Mitchell, T. C., Bouillet, P., Strasser, A., Kappler, J., & Marrack, P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00322-9 · Cited by 567
T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis
Critchfield, J. M., Racke, M. K., Zúñiga-Pflücker, J. C., Cannella, B., Raine, C. S., Goverman, J., & Lenardo, M. J. (1994) · Science · doi:10.1126/science.7509084 · Cited by 524
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493
Self-citationRosenberg, S. A., Sherry, R. M., Morton, K. E., Scharfman, W. J., Yang, J. C., Topalian, S. L., Royal, R. E., Kammula, U., Restifo, N. P., Hughes, M. S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6169 · Cited by 465
Interferon γ Is Required for Activation-induced Death of T Lymphocytes
Refaeli, Y., Van Parijs, L., Alexander, S. I., & Abbas, A. K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020666 · Cited by 417
Ahonen, C. L., Doxsee, C. L., McGurran, S. M., Riter, T. R., Wade, W. F., Barth, R. J., Vasilakos, J. P., Noelle, R. J., & Kedl, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031591 · Cited by 362
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Löwik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Drijfhout, J. W., Wafelman, A. R., Oostendorp, J., Fleuren, G. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1881 · Cited by 315
Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.
Toes, R. E., Offringa, R., Blom, R. J., Melief, C. J., & Kast, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7855 · Cited by 292
Bijker, M. S., van den Eeden, S. J. F., Franken, K. L., Melief, C. J. M., Offringa, R., & van der Burg, S. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5033 · Cited by 279
Schuster, S. J., Neelapu, S. S., Gause, B. L., Janik, J. E., Muggia, F. M., Gockerman, J. P., Winter, J. N., Flowers, C. R., Nikcevich, D. A., Sotomayor, E. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3005 · Cited by 245
Bijker, M. S., van den Eeden, S. J. F., Franken, K. L., Melief, C. J. M., van der Burg, S. H., & Offringa, R. (2008) · European Journal of Immunology · doi:10.1002/eji.200737995 · Cited by 229
T cell priming versus T cell tolerance induced by synthetic peptides.
Aichele, P., Brduscha-Riem, K., Zinkernagel, R. M., Hengartner, H., & Pircher, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.261 · Cited by 229
Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis
Wojciechowski, S., Tripathi, P., Bourdeau, T., Acero, L., Grimes, H. L., Katz, J. D., Finkelman, F. D., & Hildeman, D. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070618 · Cited by 227
Peripheral Tolerance of CD8 T Lymphocytes
Redmond, W. L., & Sherman, L. A. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.010 · Cited by 227
Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen
Ugel, S., Peranzoni, E., Desantis, G., Chioda, M., Walter, S., Weinschenk, T., Ochando, J. C., Cabrelle, A., Mandruzzato, S., & Bronte, V. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.006 · Cited by 219
Rabinovich, B. A., Ye, Y., Etto, T., Chen, J. Q., Levitsky, H. I., Overwijk, W. W., Cooper, L. J. N., Gelovani, J., & Hwu, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804105105 · Cited by 208
Self-citationSpeetjens, F. M., Kuppen, P. J. K., Welters, M. J. P., Essahsah, F., Voet van den Brink, A. M. E. G., Lantrua, M. G. K., Valentijn, A. R. P. M., Oostendorp, J., Fathers, L. M., Nijman, H. W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2227 · Cited by 185
Harnessing the Power of the Immune System to Target Cancer
Lizee, G. A., Overwijk, W. W., Radvanyi, L. G., Gao, J., Sharma, P., & Hwu, P. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-112311-083918 · Cited by 157
Self-citationAppay, V., Jandus, C., Voelter, V., Reynard, S., Coupland, S. E., Rimoldi, D., Líénard, D., Guillaume, P., Krieg, A. Μ., Cerottini, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1670 · Cited by 152
Recruitment of Antigen-Specific CD8 + T Cells in Response to Infection Is Markedly Efficient
van Heijst, J. W. J., Gerlach, C., Swart, E., Sie, D., Nunes-Alves, C., Kerkhoven, R. M., Arens, R., Correia-Neves, M., Schepers, K., & Schumacher, T. N. M. (2009) · Science · doi:10.1126/science.1175455 · Cited by 146
Leffers, N., Lambeck, A. J. A., Gooden, M. J. M., Hoogeboom, B. N., Wolf, R., Hamming, I. L. E., Hepkema, B. G., Willemse, P. H. B., Molmans, B. H. W., Hollema, H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24597 · Cited by 144
Reinhardt, R. L., Bullard, D. C., Weaver, C. T., & Jenkins, M. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021690 · Cited by 144
Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment
Gajewski, T. F., Fuertes, M. B., Spaapen, R. M., Zheng, Y., & Kline, J. P. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.11.013 · Cited by 138
Rezvani, K., Yong, A. S. M., Mielke, S., Jafarpour, B., Savani, B. N., Le, R., Eniafe, R. B., Musse, L., Boss, C., Kurlander, R. J., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.031674 · Cited by 122
Bim mediates apoptosis of CD127lo effector T cells and limits T cell memory
Wojciechowski, S., Jordan, M. B., Zhu, Y., White, J., Zajac, A. J., & Hildeman, D. A. (2006) · European Journal of Immunology · doi:10.1002/eji.200635897 · Cited by 121
Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms
Lizee, G. A., Radvanyi, L. G., Overwijk, W. W., & Hwu, P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0944 · Cited by 109
Self-citationImmunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant
Overwijk, W. W., de Visser, K. E., Tirion, F. H., de Jong, L. A., Pols, T. W. H., van der Velden, Y. U., van den Boorn, J. G., Keller, A. M., Buurman, W. A., Theoret, M. R., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5213 · Cited by 84
Self-citationKedl, R. M., Jordan, M. B., Potter, T. A., Kappler, J. W., Marrack, P., & DOW, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191371898 · Cited by 80
Loss of CTL Function among High-Avidity Tumor-Specific CD8+ T Cells following Tumor Infiltration
Janicki, C. N., Jenkinson, S. R., Williams, N., & Morgan, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5008 · Cited by 72
den Boer, A. T., Diehl, L., van Mierlo, G. J. D., van der Voort, E. I. H., Fransen, M. F., Krimpenfort, P., Melief, C. J. M., Offringa, R., & Toes, R. E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2522 · Cited by 69
Graham, B. S., McElrath, M. J., Keefer, M. C., Rybczyk, K., Berger, D., Weinhold, K. J., Ottinger, J. S., Ferrari, G., Montefiori, D. C., Stablein, D. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011995 · Cited by 68
Effect of Long-term Storage in TRIzol on Microarray-Based Gene Expression Profiling
Ma, W., Wang, M. L., Wang, Z., Sun, L., Graber, D., Matthews, J. A., Champlin, R., Yi, Q., Orlowski, R. Z., Kwak, L. W., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0565 · Cited by 56
Self-citationAdjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy
Verdeil, G., Marquardt, K., Surh, C. D., & Sherman, L. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805054105 · Cited by 52
Assessing Clusters and Motifs from Gene Expression DataPreprint
Jakt, L. M., Cao, L., Cheah, K. S. E., et al. (2001) · Genome Research · doi:10.1101/gr.148301 · Cited by 51
Ly, L. V., Sluijter, M., Versluis, M., Luyten, G. P. M., van der Burg, S. H., Melief, C. J. M., Jager, M. J., & van Hall, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2288 · Cited by 50
Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells
Muraoka, D., Kato, T., Wang, L., Maeda, Y., Noguchi, T., Harada, N., Takeda, K., Yagita∥, H., Guillaume, P., Luescher, I. F., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903649 · Cited by 50
Schaefer, J. T., Patterson, J. W., Deacon, D. H., Smolkin, M. E., Petroni, G. R., Jackson, E. M., & Slingluff, C. L. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-79 · Cited by 49
den Boer, A. T., van Mierlo, G. J. D., Fransen, M. F., Melief, C. J. M., Offringa, R., & Toes, R. E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6074 · Cited by 41
The duration of TCR/pMHC interactions regulates CTL effector function and tumor‐killing capacity
Riquelme, E. M., Carreño, L. J., González, P. A., & Kalergis, A. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200939341 · Cited by 34
Toward improved immunocompetence of adoptively transferred CD8+ T cells
Speiser, D. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25427 · Cited by 30
Hambach, L., Aghai, Z., Pool, J., Kröger, N. M., & Goulmy, E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000213 · Cited by 12
Cited by
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Peng, W., Chen, J. Q., Liu, C., Malu, S., Creasy, C., Tetzlaff, M. T., Xu, C., McKenzie, J. A., Zhang, C., Liang, X., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0283 · Cited by 1,539
Self-citationRethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Turning the corner on therapeutic cancer vaccines
Hollingsworth, R. E., & Jansen, K. (2019) · npj Vaccines · doi:10.1038/s41541-019-0103-y · Cited by 689
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Chongsathidkiet, P., Jackson, C., Koyama, S., Loebel, F., Cui, X., Farber, S. H., Woroniecka, K., Elsamadicy, A. A., Dechant, C. A., Kemeny, H. R., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0135-2 · Cited by 668
Metadata
- Authors
- Hailemichael, Y., Dai, Z., Jaffarzad, N., Ye, Y., Medina, M. A., Huang, X.-F., Dorta-Estremera, S. M., Greeley, N. R., Nitti, G., Peng, W., Liu, C., Lou, Y., Wang, Z., Ma, W., Rabinovich, B., Sowell, R. T., Schluns, K. S., Davis, R. E., Hwu, P., & Overwijk, W. W.
- Venue
- Nature Medicine
- Published
- 2013-03-03
- Volume
- 19
- Issue
- 4
- Pages
- 465-472
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2038632547
- Cited by
- 457
- References
- 60
- FWCI
- 24.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.